Rivastigmine
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2520 publications
Rational Design and Evaluation of Rivastigmine-Based Pleiotropic Prodrugs for the Treatment of Alzheimer's Disease.
Journal: ACS chemical neuroscience
Published: April 13, 2026
Computational toxicity profiling of the UV stabilizer UV-328 against the human brain enzyme acetylcholinesterase.
Journal: International journal of environmental health research
Published: April 13, 2026
Incidence of amyloid-related imaging abnormalities and health resource utilization in patients with Alzheimer disease receiving monoclonal antibody treatments: A real-world evidence study.
Journal: Journal of managed care & specialty pharmacy
Published: March 26, 2026
Comparison table: Drugs for Alzheimer's disease dementia.
Journal: The Medical letter on drugs and therapeutics
Published: March 24, 2026
Cost-effectiveness of traditional and novel neurotherapeutic agents for Alzheimer's disease: A systematic review.
Journal: Journal of Alzheimer's disease : JAD
Published: March 16, 2026
Occurrence Characteristics and Associated Factors of Alzheimer's Disease Drugs in Wastewater in China
Journal: Huan jing ke xue= Huanjing kexue
Published: March 14, 2026
Dystonia induced by anticholinesterase drugs: case report and literature review.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: February 25, 2026
Structure-Based Design of New Series of Sulfonates with Potent and Specific BChE Inhibition and Anti-Inflammatory Effects.
Journal: International journal of molecular sciences
Published: February 05, 2026
Treatment persistence with acetylcholinesterase inhibitors in Alzheimer's disease: Real-world evidence from a retrospective cohort study.
Journal: Journal of Alzheimer's disease : JAD
Published: January 28, 2026
Brain-targeted mucoadhesive in situ gel incorporating quercetin-PEG conjugate and rivastigmine-loaded chitosan nanoparticles for Alzheimer's therapy.
Journal: International journal of biological macromolecules
Published: January 14, 2026
Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment.
Journal: Journal of Alzheimer's disease : JAD
Published: January 13, 2026
Last Updated: 04/28/2026